As a consequence, research on AD development and progression has been mainly focused on the understanding of the molecular mechanisms underpinning these two pathognomonic features, leading to the identification of amyloid beta (Aβ) peptides accumulation and tau fibrils hyperphosphorylation. The gene discussed is MAPT; the disease is Alzheimer disease.